Vestal Point Capital’s Transmedics TMDX Stock Holding History

Vestal Point Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,000	Closed	-$3.12M	–	82
2024 Q4	$3.12M	Buy	+50,000	New	+$4.65M	0.18%	62

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestal Point Capital's TMDX Position: Q1 2025 in Review

Vestal Point Capital sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 50,000 shares — an estimated $3.12M sold.

Vestal Point Capital first reported a position in TMDX in Q4 2024 and held it in 1 quarter. The position peaked at $3.12M in Q4 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

Vestal Point Capital reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
Vestal Point Capital sold 50,000 Transmedics shares in Q1 2025, an estimated $3.12M.
Vestal Point Capital first reported a position in Transmedics in Q4 2024 and held it in 1 quarter.
Vestal Point Capital's Transmedics position peaked at $3.12M in Q4 2024.
298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Vestal Point Capital's 13F filing for Q1 2025, filed 15 May 2025.